デフォルト表紙
市場調査レポート
商品コード
1622413

褥瘡治療市場規模、シェア、成長分析、製品タイプ別、創傷タイプ別、エンドユーザー別、地域別 - 産業予測、2025~2032年

Pressure Ulcers Treatment Market Size, Share, Growth Analysis, By Product Type (Wound Care Dressings, Active Wound Care Therapies), By Wound Type (Stage 1, Stage 2), By End-User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 165 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
褥瘡治療市場規模、シェア、成長分析、製品タイプ別、創傷タイプ別、エンドユーザー別、地域別 - 産業予測、2025~2032年
出版日: 2024年12月22日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

褥瘡治療市場規模は2023年に61億米ドルと評価され、予測期間(2025-2032年)のCAGRは5.2%で、2024年の64億2,000万米ドルから2032年には99億9,000万米ドルに成長する見通しです。

褥瘡による慢性疾患や身体障害に苦しむ高齢者人口の増加により、医療分野における効果的な治療に対する需要が大幅に高まっています。褥瘡治療市場の主な促進要因としては、先進的な創傷ケア機器や治療法が利用可能であるにもかかわらず、ヘルスケア機関がこの複雑な問題に取り組んでいるため、管理と革新的なソリューションが緊急に必要であることが挙げられます。褥瘡の治療にかかる費用は予防にかかる費用をはるかに上回ることから、ヘルスケア施設では予防ケアへの取り組みへのシフトが顕著になっています。先進的な動作モニタリングシステムは、患者ケアの向上と潰瘍発生率の低減のために統合されつつあり、デジタルソリューションはヘルスケアのデジタル変革が進む中で普及しつつあります。その結果、褥瘡が患者の健康に与える影響に対する認識が高まり、治療ソリューションの需要が大幅に増加する見通しです。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ

褥瘡治療市場規模:製品タイプ別

  • 市場概要
  • 創傷ケア用ドレッシング
    • フォームドレッシング
    • ハイドロコロイドドレッシング
    • アルギン酸塩ドレッシング
    • フィルムドレッシング
    • ハイドロゲルドレッシング
  • 積極的な創傷ケア療法
    • 皮膚代替品
    • 成長因子
  • 創傷ケア機器
    • 陰圧閉鎖療法(NPWT)デバイス
    • 高圧酸素装置
    • 電気刺激装置
  • その他の製品タイプ
    • 伝統的な創傷ケア製品
    • その他

褥瘡治療市場規模:創傷タイプ別

  • 市場概要
  • ステージ 1
  • ステージ 2
  • ステージ 3
  • ステージ 4

褥瘡治療市場規模:エンドユーザー別

  • 市場概要
  • 病院
  • クリニック
  • 在宅ヘルスケア
  • 長期ケアセンター

褥瘡治療市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Smith & Nephew plc(UK)
  • 3M Healthcare(USA)
  • Molnlycke Health Care AB(Sweden)
  • Coloplast A/S(Denmark)
  • ConvaTec Group plc(UK)
  • Integra LifeSciences(USA)
  • Medtronic plc(Ireland)
  • Cardinal Health, Inc.(USA)
  • B. Braun Melsungen AG(Germany)
  • Paul Hartmann AG(Germany)
  • Acelity L.P. Inc.(USA)
  • Derma Sciences, Inc.(USA)
  • Organogenesis Inc.(USA)
  • Hollister Incorporated(USA)
  • Medline Industries, Inc.(USA)
  • Coloplast Corp.(USA)
  • BSN Medical GmbH(Germany)
  • Lohmann & Rauscher GmbH & Co. KG(Germany)
  • Systagenix Wound Management, Ltd.(UK)

結論と推奨事項

目次
Product Code: SQMIG35D2045

Pressure Ulcers Treatment Market size was valued at USD 6.1 Billion in 2023 and is poised to grow from USD 6.42 Billion in 2024 to USD 9.99 Billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The increasing geriatric population suffering from chronic illnesses and physical impairments due to pressure ulcers has significantly heightened the demand for effective treatments in the medical sector. Key drivers in the pressure ulcer treatment market include the urgent need for management and innovative solutions, as healthcare institutions grapple with this complex issue despite the availability of advanced wound care devices and therapies. Given that the costs associated with treating pressure ulcers far exceed those of prevention, there's a notable shift towards preventative care initiatives within healthcare facilities. Advanced movement monitoring systems are being integrated to improve patient care and reduce ulcer incidence, while digital solutions are gaining traction amid the ongoing digital transformation in healthcare. Consequently, rising awareness of pressure ulcers' impact on patient well-being is poised to drive substantial growth in demand for treatment solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pressure Ulcers Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pressure Ulcers Treatment Market Segmental Analysis

Global Pressure Ulcers Treatment Market is segmented by product type, wound type, end-user and region. Based on product type, the market is segmented into wound care dressings, active wound care therapies, wound care devices and other product types. Based on wound type, the market is segmented into stage 1, stage 2, stage 3 and stage 4. Based on end-user, the market is segmented into hospitals, clinics, home healthcare and long-term care centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pressure Ulcers Treatment Market

The pressure ulcers treatment market is poised for growth driven by several key factors. The rising prevalence of pressure ulcers, coupled with increasing healthcare expenditures and a growing geriatric demographic, significantly contributes to this expansion. Additionally, the adoption of advanced artificial skin substitutes and heightened government funding plays a crucial role. Initiatives undertaken by both government and private sectors to promote awareness about the detrimental effects of pressure ulcers on patient health and quality of life further bolster market growth. Moreover, enhanced research and development efforts, alongside high unmet medical needs and the advancement of treatment and diagnostic methodologies, present valuable opportunities for the market from 2022 to 2028.

Restraints in the Pressure Ulcers Treatment Market

The Pressure Ulcers Treatment market faces significant challenges due to the high treatment costs and limited reimbursement policies, particularly in low-income nations. These financial barriers can hinder market growth and create obstacles for patients seeking effective pressure ulcer care. In many cases, reimbursement options for both new and innovative treatments are minimal, leaving healthcare providers struggling to offer these solutions without adequate insurance coverage. Consequently, the lack of financial support and favorable reimbursement for advanced treatment methods may deter healthcare facilities from implementing the latest technologies, ultimately impacting patient outcomes and market expansion during the forecast period.

Market Trends of the Pressure Ulcers Treatment Market

The Pressure Ulcers Treatment market is witnessing a significant trend towards the increasing adoption of polyurethane foam dressings, renowned for their semipermeable properties that enhance wound healing. These dressings, available in both adhesive and non-adhesive variants, are being widely utilized for various wound types, including leg ulcers, surgical sites, infected wounds, burns, abrasions, and lacerations. The growing recognition of the benefits these dressings offer-such as moisture retention, comfort, and reduced infection rates-coupled with a rising geriatric population and chronic disease prevalence, are driving market expansion. As healthcare systems prioritize effective wound management solutions, polyurethane foam dressings are poised to dominate the landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Pressure Ulcers Treatment Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Wound Care Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Alginate Dressings
    • Film Dressings
    • Hydrogel Dressings
  • Active Wound Care Therapies
    • Skin Substitutes
    • Growth Factors
  • Wound Care Devices
    • Negative Pressure Wound Therapy (NPWT) Devices
    • Hyperbaric Oxygen Equipment
    • Electrical Stimulation Devices
  • Other Product Types
    • Traditional Wound Care Products
    • Others

Global Pressure Ulcers Treatment Market Size by Wound Type & CAGR (2025-2032)

  • Market Overview
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4

Global Pressure Ulcers Treatment Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Home Healthcare
  • Long-Term Care Centers

Global Pressure Ulcers Treatment Market Size & CAGR (2025-2032)

  • North America (Product Type, Wound Type, End-User)
    • US
    • Canada
  • Europe (Product Type, Wound Type, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Wound Type, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Wound Type, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Wound Type, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Smith & Nephew plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Paul Hartmann AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acelity L.P. Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Derma Sciences, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Organogenesis Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast Corp. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BSN Medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lohmann & Rauscher GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systagenix Wound Management, Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations